How are you incorporating new treatment options into your clinical practice for patients with urothelial cancer?
Download this PDF clinical resource on toxicity management to help optimize the care of your patients with progressive urothelial carcinoma receiving erdafitinib or enfortumab vedotin.
Download this PDF patient safety guide for a quick resource on signs and symptoms of specific AEs patients should look for while they are receiving erdafitinib or enfortumab vedotin.
Download this PDF clinical resource for an overview on treatment options for your patients with advanced urothelial carcinoma, highlighting recently approved agents.
Review slides with commentary in slidenotes from pharmacist and nursing experts on patient counseling, monitoring, and managing adverse events associated with avelumab, enfortumab vedotin, and erdafitinib in urothelial carcinoma.
Listen as Kinjal Patel, PharmD, BCOP, discusses the most recent data on new treatment options for patients with advanced or metastatic urothelial carcinoma.
Kinjal Patel, PharmD, BCOP, discusses the mechanism of action, indication and treatment considerations when using enfortumab vedotin for patients with advanced or metastatic urothelial carcinoma.
Kinjal Patel, PharmD, BCOP, discusses the mechanism of action, indication, and treatment considerations when using erdafitinib for patients with advanced or metastatic urothelial carcinoma.
Review important nursing considerations and tips for educating patients undergoing treatment with erdafitinib or enfortumab vedotin for advanced urothelial carcinoma.
Listen as Susan K. Roethke, CRNP, MSN, AOCNP, ANP-BC, discusses optimal management of common AEs associated with enfortumab vedotin treatment in patients with advanced or metastatic urothelial carcinoma.
Listen as Susan K. Roethke, CRNP, MSN, AOCNP, ANP-BC, discusses optimal management of common AEs associated with erdafitinib treatment in patients with advanced or metastatic urothelial carcinoma.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.